Received Feb 9, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | UNK | NA4452 | IM / RA |
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | 1 | 946915 | IM / LA |
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 955E2 | IM / LA |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | 1 | Z011601 | SC / RA |
Patient felt overheated and nausea and vomiting within a few minutes of vaccine administration. She was observed for 15 minutes before leaving the pharmacy and patient stated she felt better before leaving. After following up over the phone with the patient about 5 hours later, she reported developing a rash on neck and forearm that lasted about 2 hours and then went away. She reported no other reaction after the rash cleared.
N/A
N/A
N/A
NKA